Jump to content

TYK320

From PedsAnesthesiaNet
Revision as of 02:34, 25 September 2026 by WikiSysop (talk | contribs) (Text replacement - "<p style="text-align: center;"> About Test Your Knowledge</p>" to "<p style="text-align: center;"> About Test Your Knowledge</p> Category:TYK")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Children presenting with pheochromocytoma should be tested for:

a) von Hipple-Lindau disease

b) Neurofibromatosis type 1

c) Multiple endocrine neoplasia, type 2

d) Succinate dehydrogenase mutations

e) All of the above

Click for Answer

Answer

Answer e. 40% of pheochromocytomas in children are associated with these genetic conditions. All young patients (under 50) should be offered genetic screening, especially as the succinate dehydrogenase mutations are associated with a high risk of malignancy.

Notes

This question originally printed in the Pediatric Anesthesiology Review Topics kindle book series, and appears courtesy of Naerthwyn Press, LLC.

Keywords



<Prev Question --- Next Question>

About Test Your Knowledge